InsidersTradesSigma
Follow the Britannia Life Sciences Inc. stock price and the full management transaction log of the company, a listed issuer based in Canada. Shares are quoted on the CA market, under the authority of SEDI. Market capitalisation: €6.6m. The latest transaction was disclosed on 21 July 2026 (54 - Exercise of warrants). Among the most active insiders: Shippen, Peter James. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Britannia Life Sciences Inc. is a company listed on the Toronto Stock Exchange, specializing in the life sciences sector. It focuses on developing innovative solutions to enhance health and well-being.